Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19

17Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Sharma, C., Jha, N. K., Meeran, M. F. N., Patil, C. R., Goyal, S. N., & Ojha, S. (2021). Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.603997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free